Some of the content on this page has been created using generative AI.
What is it about?
Benign prostatic hyperplasia (BPH) affects millions globally, with men often facing complex treatment decisions. This study reviews decision aids (DAs) designed to support shared decision making (SDM) in BPH treatment, distinct from prostate cancer aids. It analyzed 1979 records, with 13 studies meeting criteria, highlighting 10 DAs. Findings suggest that DAs often lack strong theoretical foundations and fail to effectively incorporate patient preferences and values. The most effective DAs use behavior change techniques and integrate patient priorities. The review calls for more transparent research, linking DAs to behavioral theories and testing them in relevant clinical settings to improve SDM. Methodological limitations and medium-to-high risk of bias were identified in the reviewed studies, underscoring the need for improved development and implementation of DAs in urological practice.
Featured Image
Photo by Online Marketing on Unsplash
Why is it important?
This research is important because it addresses the critical issue of shared decision making (SDM) in the treatment of benign prostatic hyperplasia (BPH), a prevalent condition affecting millions of men worldwide. By evaluating the effectiveness of decision aids (DAs) in facilitating SDM, the study contributes to enhancing patient-centered care, ensuring that treatment decisions align with individual patient preferences and values. Furthermore, the research identifies gaps in current DAs, such as the lack of integration with behavioral theories and transparency, which are vital for improving urological practices and patient outcomes. Key Takeaways: 1. Importance of SDM: The research underscores the necessity of incorporating patient preferences and expectations in treatment discussions, highlighting SDM as a crucial component of healthcare delivery for BPH management. 2. Evaluation of Decision Aids: The study reveals that while DAs can provide valuable information, their effectiveness is heightened when they incorporate patient preferences and values, suggesting a need for more comprehensive and theoretically grounded interventions. 3. Future Research Directions: The findings advocate for future studies to focus on transparent reporting and integration of psychological theories in DAs, to enhance their implementation in clinical practice and improve patient satisfaction and decision-making processes.
AI notice
Read the Original
This page is a summary of: Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia, BJU International, May 2025, Wiley,
DOI: 10.1111/bju.16797.
You can read the full text:
Contributors
The following have contributed to this page







